Evidence map›Paper›PMID 35763661›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2022

A Novel Method for Improving VMAT Plan Quality and Deliverability.

Natarajan Ramar, Samir Ranjan Meher

Open access · goldAbstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Natarajan RamarPhilips Health Systems, Philips India Ltd, Bangalore, India.
Samir Ranjan MeherDepartment of Physics, School of Advanced Sciences, Vellore Institute of Technology, Vellore, India.
Philips (India) · INVellore Institute of Technology University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA new VMAT method called "Augmented Arc" (or simply Aug Arc) is proposed. The aim of this study is to demonstrate the validity of the proposed method in different clinical cases. Basically, Aug Arc refers to the portion(s) of the VMAT arc that is augmented with an additional arc to improve the plan quality. The Aug Arc portions in the Arc is determined using an objective function-based scoring method called "ψ - score".

methodsTo validate our approach, we have applied it in four clinical cases: Lung, Abdomen, Gynecologic (Gyn) and Pancreas. Basically, for Lung and Pancreas cases, four sets of plans were created, which are: (1) Single arc plan (S Arc), (2) Double arc plan (D Arc), (3) Partial Arc plan without Aug Arc (P Arc) and (4) Partial plan with Aug Arc (P+Aug Arc). For Abdomen and Gyn cases, three sets of plans were created, which are: (1) Single arc plan (S Arc), (2) Double arc plan (D Arc) and (3) Single Arc with Aug Arc (S+Aug Arc). To compute the "ψ - score", an initial optimization was performed by using full Arc with 4-degree gantry spacing. Subsequently, Aug Arc portions were identified using the ψ - score plot in the single arc and partial arc scenarios.

resultsThe study finds that the proposed method is useful to improve the plan quality and plan deliverability for both centrically and non-centrically located tumors in terms of reducing the OAR dose, monitor units, beam on time and low dose volume without compromising the target coverage.

conclusionThe results indicate that the proposed approach could strike a balance between full double arc and single arc or partial arc in such a way that the planner can find a sweet spot of delivery parameters that result in optimal plan quality.

Indexed as

NeoplasmsRadiotherapy, Intensity-ModulatedFemaleHumansRadiotherapy DosageRadiotherapy Planning, Computer-AssistedResearch DesignControl pointIMRTObjective functionPartial ArcVMAT

Identifiers

PMID35763661
PMCPMC9587845
OpenAlexW4283709751

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.